Samsrita Labs Proposes 50% Capital Reduction to Set Off ₹11.37 Crore Losses

Board approved scheme of capital reduction to cancel 11.37 Cr equity shares on a pro-rata basis, reducing paid-up capital to set off accumulated losses of ~11.58 Cr. Approved entry into pet animal healthcare business via MOA alteration. Appointed Mr. Ravi Kanth Chopperla as Non-Executive Professional Additional Director. Proposed related party transactions with QROPS Advisory Services. AGM set for 10 Aug 2026.